miR-181b negatively regulates activation-induced cytidine deaminase in B cells
Open Access
- 1 September 2008
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 205 (10) , 2199-2206
- https://doi.org/10.1084/jem.20080579
Abstract
Activated B cells reshape their primary antibody repertoire after antigen encounter by two molecular mechanisms: somatic hypermutation (SHM) and class switch recombination (CSR). SHM and CSR are initiated by activation-induced cytidine deaminase (AID) through the deamination of cytosine residues on the immunoglobulin loci, which leads to the generation of DNA mutations or double-strand break intermediates. As a bystander effect, endogenous AID levels can also promote the generation of chromosome translocations, suggesting that the fine tuning of AID expression may be critical to restrict B cell lymphomagenesis. To determine whether microRNAs (miRNAs) play a role in the regulation of AID expression, we performed a functional screening of an miRNA library and identified miRNAs that regulate CSR. One such miRNA, miR-181b, impairs CSR when expressed in activated B cells, and results in the down-regulation of AID mRNA and protein levels. We found that the AID 3' untranslated region contains multiple putative binding sequences for miR-181b and that these sequences can be directly targeted by miR-181b. Overall, our results provide evidence for a new regulatory mechanism that restricts AID activity and can therefore be relevant to prevent B cell malignant transformation.Keywords
This publication has 30 references indexed in Scilit:
- Two levels of protection for the B cell genome during somatic hypermutationNature, 2008
- A role for AID in chromosome translocations between c-myc and the IgH variable regionThe Journal of Experimental Medicine, 2007
- Role of genomic instability and p53 in AID-induced c-myc–Igh translocationsNature, 2006
- Immunoglobulin Gene DiversificationAnnual Review of Genetics, 2005
- Mechanisms of B-cell lymphoma pathogenesisNature Reviews Cancer, 2005
- AID Is Required for c-myc/IgH Chromosome Translocations In VivoCell, 2004
- AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversificationNature, 2002
- Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing EnzymeCell, 2000
- Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)Cell, 2000
- Antibody Class SwitchingPublished by Elsevier ,1996